Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Non-cash Items (2020 - 2025)

Biodesix's Non-cash Items history spans 6 years, with the latest figure at $168000.0 for Q4 2025.

  • For Q4 2025, Non-cash Items fell 76.6% year-over-year to $168000.0; the TTM value through Dec 2025 reached $168000.0, down 76.6%, while the annual FY2025 figure was $168000.0, 76.6% down from the prior year.
  • Non-cash Items reached $168000.0 in Q4 2025 per BDSX's latest filing, up from $27000.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $20.8 million in Q2 2021 to a low of $27000.0 in Q3 2025.
  • Average Non-cash Items over 5 years is $2.9 million, with a median of $1.4 million recorded in 2022.
  • Peak YoY movement for Non-cash Items: skyrocketed 6429.93% in 2021, then tumbled 98.43% in 2025.
  • A 5-year view of Non-cash Items shows it stood at $6.3 million in 2021, then tumbled by 76.32% to $1.5 million in 2022, then tumbled by 35.26% to $964000.0 in 2023, then decreased by 25.52% to $718000.0 in 2024, then plummeted by 76.6% to $168000.0 in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Non-cash Items are $168000.0 (Q4 2025), $27000.0 (Q3 2025), and $2.8 million (Q2 2025).